Medigus Ltd.
Simbols: MDGS
NASDAQ
2.745
USDTirgus cena šodien
-0.2062
P/E koeficients
-0.0022
PEG koeficients
4.67M
MRK Cap
- 0.00%
DIV ienesīgums
Medigus Ltd. (MDGS) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 79.33 | 25.1 | 27.3 | 22.4 | ||||||||||
balance-sheet.row.short-term-investments | 8.11 | 5 | 3.3 | 0 | ||||||||||
balance-sheet.row.net-receivables | 94.87 | 25.2 | 1.7 | 0.3 | ||||||||||
balance-sheet.row.inventory | 8.67 | 1.8 | 1.2 | 0.2 | ||||||||||
balance-sheet.row.other-current-assets | 21.11 | 0.2 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.total-current-assets | 197.6 | 52.3 | 31.7 | 24 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 3.82 | 1 | 0.1 | 0.4 | ||||||||||
balance-sheet.row.goodwill | 36.23 | 9.1 | 0.9 | 0.3 | ||||||||||
balance-sheet.row.intangible-assets | 87.71 | 21.8 | 7.4 | 0.5 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 123.94 | 30.9 | 8.3 | 0.5 | ||||||||||
balance-sheet.row.long-term-investments | 39.56 | 13.1 | 18.8 | 6.2 | ||||||||||
balance-sheet.row.tax-assets | 0.85 | 0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | -83.66 | 0 | 0.8 | 1.2 | ||||||||||
balance-sheet.row.total-non-current-assets | 168.18 | 45.4 | 28.1 | 8.3 | ||||||||||
balance-sheet.row.other-assets | 0.85 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 366.64 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.account-payables | 78.02 | 20.4 | 0.7 | 0.1 | ||||||||||
balance-sheet.row.short-term-debt | 14.76 | 6.7 | 0.9 | 0.1 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 12.98 | 3.4 | 0.7 | 0 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 2.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.56 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 49.74 | 10.4 | 4.9 | 3.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 16.68 | 5.3 | 1.7 | 2.6 | ||||||||||
balance-sheet.row.other-liabilities | 4.67 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 1.25 | 0.6 | 0 | 0.1 | ||||||||||
balance-sheet.row.total-liab | 168.36 | 43 | 8.3 | 6.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 93 | ||||||||||
balance-sheet.row.retained-earnings | -358.74 | -85.6 | -74.2 | -81 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 26.97 | 13.2 | 12.6 | 10.7 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 473.58 | 111.5 | 110.8 | 0.2 | ||||||||||
balance-sheet.row.total-stockholders-equity | 141.81 | 39.1 | 49.2 | 23 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 183.32 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.minority-interest | 56.46 | 15.5 | 2.2 | 3.2 | ||||||||||
balance-sheet.row.total-equity | 198.27 | 54.7 | 51.4 | 26.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 183.32 | - | - | - | ||||||||||
Total Investments | 47.67 | 18.1 | 22.2 | 6.2 | ||||||||||
balance-sheet.row.total-debt | 21.73 | 10.1 | 1.6 | 0.1 | ||||||||||
balance-sheet.row.net-debt | -43.12 | -9.9 | -22.4 | -22.3 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.79 | -10.1 | 4.2 | -6.8 | |||||||||||
cash-flows.row.depreciation-and-amortization | 5.1 | 3.2 | 0.3 | 0.2 | |||||||||||
cash-flows.row.deferred-income-tax | -5.51 | 0.4 | -12.8 | -1.1 | |||||||||||
cash-flows.row.stock-based-compensation | 0.63 | 0.8 | 2.4 | 1.4 | |||||||||||
cash-flows.row.change-in-working-capital | -2.08 | -1.1 | 0.1 | -0.3 | |||||||||||
cash-flows.row.account-receivables | -3.62 | -7.8 | -0.2 | -0.1 | |||||||||||
cash-flows.row.inventory | -1.09 | -0.6 | -0.6 | -0.5 | |||||||||||
cash-flows.row.account-payables | 3.64 | 5.8 | 1 | 0.1 | |||||||||||
cash-flows.row.other-working-capital | -1.01 | 1.4 | -0.1 | 0.2 | |||||||||||
cash-flows.row.other-non-cash-items | 14.17 | 1.2 | 0.6 | 0.5 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -9.5 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.acquisitions-net | -2.92 | -2.4 | -7.7 | -1.3 | |||||||||||
cash-flows.row.purchases-of-investments | -2.86 | -6.6 | -0.2 | -1.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 1.24 | 0.5 | 1.9 | 3.1 | |||||||||||
cash-flows.row.other-investing-activites | -5.45 | 4.1 | -6.2 | -1.3 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.79 | -4.5 | -12.4 | -1.6 | |||||||||||
cash-flows.row.debt-repayment | -3.32 | -4.7 | -1.5 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 13.25 | 12.6 | 18.7 | 23 | |||||||||||
cash-flows.row.common-stock-repurchased | -2.38 | 0 | 0 | -22.9 | |||||||||||
cash-flows.row.dividends-paid | -7.11 | -4.2 | 0 | -0.1 | |||||||||||
cash-flows.row.other-financing-activites | 1.72 | 1.8 | 1.9 | 0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.18 | 5.4 | 19.1 | 22.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.88 | 0.8 | 0.2 | 0.1 | |||||||||||
cash-flows.row.net-change-in-cash | -14.71 | -4 | 1.7 | 15.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 50.04 | 20.1 | 24 | 22.4 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 64.75 | 24 | 22.4 | 7 | |||||||||||
cash-flows.row.operating-cash-flow | -9.5 | -5.7 | -5.3 | -6.1 | |||||||||||
cash-flows.row.capital-expenditure | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.free-cash-flow | -11.29 | -5.7 | -5.4 | -6.5 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 166.86 | 91.9 | 10.1 | 0.5 | |||||||||||
income-statement-row.row.cost-of-revenue | 141.96 | 77.4 | 5.3 | 1 | |||||||||||
income-statement-row.row.gross-profit | 24.9 | 14.5 | 4.8 | -0.5 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 8.23 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 16.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 40.69 | 23 | 13 | 7 | |||||||||||
income-statement-row.row.cost-and-expenses | 182.65 | 100.4 | 18.3 | 8 | |||||||||||
income-statement-row.row.interest-income | 2.49 | 2.3 | 0.3 | 0.2 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 5.1 | 1.8 | -14 | -0.5 | |||||||||||
income-statement-row.row.ebitda-caps | -9.36 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -14.45 | -13.8 | -8.2 | -7.4 | |||||||||||
income-statement-row.row.income-before-tax | -20.2 | -10.1 | 4.2 | -6.8 | |||||||||||
income-statement-row.row.income-tax-expense | 0.42 | 0.1 | 0.1 | 0 | |||||||||||
income-statement-row.row.net-income | -21.79 | -10.2 | 4 | -6.8 |
Biežāk uzdotie jautājumi
Kas ir Medigus Ltd. (MDGS) kopējie aktīvi?
Medigus Ltd. (MDGS) kopējie aktīvi ir 97651000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir 80077500.000.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.150.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir -5.754.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir -0.135.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir -0.086.
Kāda ir Medigus Ltd. (MDGS) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir -10208000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 10135000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 23033000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 12359000.000.